Stress and the inflammatory response: A review of neurogenic inflammation

Brain, Behavior, and Immunity

Volumn 16, Issue 6, 2002, Pages 622-653

  Black, Paul H ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute phase response; Atherosclerosis; Cytokines; Lipopolysaccharide; Neurogenic inflammation; Stress; Substance P

Indexed keywords

ACUTE PHASE PROTEIN; CATECHOLAMINE; CORTICOSTEROID; CORTICOSTEROID RELEASING FACTOR; CYTOKINE; GLUCAGON; GROWTH HORMONE; LIPOPOLYSACCHARIDE; NEUROPEPTIDE; NORADRENALIN; RELEASING FACTOR; RENIN; SUBSTANCE P; UNCLASSIFIED DRUG;

ACUTE PHASE RESPONSE; ADRENERGIC SYSTEM; ATHEROSCLEROSIS; BRAIN; CENTRAL NERVOUS SYSTEM; CHRONIC INFLAMMATION; CYTOKINE RELEASE; GASTROINTESTINAL ABSORPTION; HORMONE RELEASE; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INFLAMMATION; INFLAMMATORY CELL; KUPFFER CELL; MACROPHAGE ACTIVATION; MAST CELL; MEDIATOR RELEASE; MENTAL STRESS; NEUROENDOCRINOLOGY; NEUROGENIC INFLAMMATION; PHYSICAL STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INDUCTION; PROTEIN SECRETION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SENSORY NERVE; STRESS;

ACUTE-PHASE REACTION; ANIMALS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; NEURITIS; NEUROIMMUNOMODULATION; STRESS;

EID: 0036911319     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-1591(02)00021-1     Document Type: Review

References (286)

1. Adachi, A., Niijima, A., & Jacobs, H. L. (1976). An hepatic osmoreceptor mechanism in the rat: Electrophysiological and behavioral studies. Am. J. Physiol., 231, 1043-1049.
2. Adams, D. O. (1994). Molecular biology of macrophage activation: A pathway whereby psychological factors can potentially affect health. Psychosom. Med., 56, 16-27.
3. Al Damluji, S. (1988). Adrenergic mechanisms in the control of corticotrophin secretion. J. Endocrinol., 119, 5-14.
4. Amerini, S., Rubino, A., Filippi, S., Ledda, F., & Mantelli, L. (1991). Modulation by adrenergic transmitters of the efferent function of capsaicin-sensitive nerves in cardiac tissue. Neuropeptides, 20, 225-232.
5. Arnalich, F., De Miguel, E., Perez-Ayala, C., Martinez, M., Vazquez, J. J., Gijon-Banos, J., & Hernanz, A. (1994). Neuropeptides and interleukin-6 in human joint inflammation; relationship betvveen intraarticular substance P and interleukin-6 concentrations. Neurosci. Lett., 170, 251-254.
6. Baluk, P. (1997). Neurogenic inflammation in skin and airvvays. J. Investig. Dermatol. Symp. Proc., 2, 76-81.
7. Basbaum, A. I., & Levine, J. D. (1991). The contribution of the nervous system to inflammation and inflammatory disease. Can. J. Physiol. Pharmacol., 69, 647-651.
8. Bascom, R., Meggs, W. J., Frampton, M., Hudnell, K., Killburn, K., Kobal, G., Medinsky, M., & Rea, W. (1997). Neurogenic inflammation: With additional discussion of central and perceptual integration of nonneurogenic inflammation. Environ. Health Perspect., 105(Suppl 2), 531-537.
9. Baumann, H., & Gauldie, J. (1994). The acute phase response. Immunol. Today, 15, 74-80.
10. Berczi, I. (1998). Neurohormonal host defense in endotoxin shock. Ann. N.Y. Acad. Sci., 840, 787-802.
11. Berliner, J. A., Navab, M., Fogelman, A. M., Frank, J. S., Derner, L. L., Edwards, P. A., Watson, A. D., & Lusis, A. J. (1995). Atherosclerosis: Basic mechanisms. Oxidation, inflammation, and genetics. Circulation, 91, 2488-2496.
12. Berman, A. S., Chancellor-Freeland, C., Zhu, G., & Black, P. H. (1996). Substance P primes murine peritoneal macrophages for an augmented proinflammatory cytokine response to lipolysaccharide. Neuroimmunomodulation, 3, 141-149.
13. Black, P. H. (1994). Central nervous system-immune system interactions: Pyschoneuroendocrinology of stress and its immune consequences. Antimicrob. Agents Chemother., 38, 1-6.
14. Black, P. H. (1995). Psychoneuroimmunology: Brain and immunity. Sci. Med., 2, 16-25.
15. Black, P. H., & Berman, A. S. (1999). Stress and Inflammation. In N. P. Plotnikoff, R. E. Faith, A. J. Murgo, & R. A. Good (Eds.), Cytokines: Stress and Immunity (pp. 115-132). Orlando: CRC Press.
16. Black, P. H., & Garbutt, L. D. (2002). Stress, inflammation and cardiovascular disease. J. Psychosomatic Research, 52, 1-23.
17. Blatteis, C. M., & Sehic, E. (1998). Cytokines and fever. Ann. N.Y. Acad. Sci., 840, 608-618.
18. Boers, W., Smit, R. A., Sala, M., Maas, A., & Chamuleau, R. A. (1992). Adrenal hormones and the regulation of acute phase protein synthesis. Folia Histochem. Cytobiol., 30, 159-160.
19. Borovikova, L. V., Ivanova, S., Zhang, M., Yang, H., Botchkina, G. I., Watkins, L. R., Wang, H., Abumrad, N., Eaton, J. W., & Tracey, K. J. (2000). Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature, 405, 458-462.
20. Brain, S. D., Newbold, P., & Kajekar, R. (1995). Modulation of the release and activity of neuropeptides in the microcirculation. Can. J. Physiol. Pharmacol., 73, 995-998.
21. Brindley, D. N., McCann, B. S., Niaura, R., Stoney, C. M., & Suarez, E. C. (1993). Stress and lipoprotein metabolism: Modulators and mechanisms. Metabolism, 42, 3-15.
22. Brindley, D. N., & Rolland, Y. (1989). Possible connections between stress, diabetes, obesity, hypertension and altered lipoprotein metabolism that may result in atherosclerosis. Clin. Sci., 77, 453-461.
23. Brodin, E., Rosen, A., Schott, E., & Brodin, K. (1994). Effects of sequential removal of rats from a group cage, and of individual housing of rats, on substance P, cholecystokinin and somatostatin levels in the periaqueductal grey and limbic regions. Neuropeptides, 26, 253-260.
24. Brunner, E. J., Marmot, M. G., Nanchahal, K., Shipley, M. J., Stansfeld, S. A., Juneja, M., & Alberti, K. G (1997). Social inequality in coronary risk: Central obesity and the metabolic syndrome. Evidence from the Whitehall II study. Diabetologia, 40, 1341-1349.
25. Buck, S. H., Walsh, J. H., Yamamura, H. L., & Burks, T. F. (1982). Neuropeptides in sensory neurons. Life Sci., 30, 1857-1866.
26. Calogero, A. E. (1995). Neurotransmitter regulation of the hypothalamic corticotropin-releasing hormone neuron. Ann. N.Y. Acad. Sci., 771, 31-40.
27. Calogero, A. E., Gallucci, W. T., Gold, P. W., & Chrousos, G. P. (1988). Multiple feedback regulatory loops upon rat hypothalamic corticotropin-releasing hormone secretion. Potential clinical implications. J. Clin. Invest., 82, 767-774.
28. Campbell, W. B., Callahan, K. S., Johnson, A. R., & Graham, R. M. (1981). Anti-platelet activity of beta-adrenergic antagonists: Inhibition of thromboxane synthesis and platelet aggregation in patients receiving long-term propranolol treatment. Lancet, 2, 1382-1384.
29. Cario, E., & Podolsky, D. K. (2000). Differential activation in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect. Immun., 68, 7010-7017.
30. Cario, E., Rosenberg, I. M., Brandwein, S. L., Beck, P. L., Reinecker, H.-C., & Podolsky, D. K. (2000). Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J. Immunol., 164, 966-972.
31. Castagliuolo, I., Keates, A. C., Qiu, B., Kelly, C. P., Nikulasson, S., Leeman, S. E., & Pothoulakis, C. (1997). Increased substance P responses in dorsal root ganglia and intestinal macrophages during Clostridium difficile toxin A enteritis in rats. Proc. Natl. Acad. Sci. USA, 94, 4788-4793.
32. Castagliuolo, I, LaMont, J. T., Qiu, B., Fleming, S. M., Bhaskar, K. R., Nikulasson, S. T., Kornetsky, C., & Pothoulakis, C. (1996a). Acute stress causes mucin release from rat colon: Role of corticotropin releasing factor and mast cells. Am. J. Physiol., 271, G884-G892.
33. Castagliuolo, I., Leeman, S. E., Bartolak-Suki, E., Nikulasson, S., Qiu, B., Carraway, R. E., & Pothoulakis, C. (1996b). A neurotensin antagonist, SR 48692, inhibits colonic responses to immobilization stress in rats. Proc. Natl. Acad. Sci. USA, 93, 12611-12615.
34. Castagliuolo, I., Riegler, M., Pasha, A., Nikulasson, S., Lu, B., Gerard, C., Gerard, N. P., & Pothoulakis, C. (1998). Neurokinin-1 (NK-1) receptor is required in Clostridium difficile-induced enteritis. J. Clin. Invest., 101, 1547-1550.
35. Castagliuolo, I., Wang, C. C., Valenick, L., Pasha, A., Nikulasson, S., Carraway, R. E., & Pothoulakis, C. (1999). Neurotensin is a proinflammatory neuropeptide in colonic inflammation. J. Clin. Invest., 103, 843-849.
36. Catania, A., Arnold, J., Macaluso, A., Hiltz, M. E., & Lipton, J. M. (1991). Inhibition of acute inflammation in the periphery by central action of salicylates. Proc. Natl. Acad. Sci. USA, 88, 8544-8547.
37. Catania, A., Delgado, R., Airaghi, L., Cutuli, M., Garofalo, L., Carlin, A., Demitri, M. T., & Lipton, J. M. (1999). α-MSH in systemic inflammation: Central and peripheral actions. In T. A. Luger, R. Paus, J. M. Lipton, & A. T. Slominski (Eds.), Cutaneous Immunomodulation (pp. 183-187). New York: New York Academy of Sciences.
38. Catania, A., Manfredi, M. G., Airaghi, L., Ceriani, G., Gandino, A., & Lipton, J. M. (1994). Cytokine antagonists in infectious and inflammatory disorders. Ann. N.Y. Acad. Sci., 741, 149-161.
39. Chahl, L. A., & Ladd, R. J. (1976). Local oedema and general excitation of cutaneous sensory receptors produced by electrical stimulation of the saphenous nerve in the rat. Pain, 2, 25-34.
40. Chancellor-Freeland, C., Zhu, G. F., Kage, R., Beller, D. I., Leeman, S. E., & Black, P. H. (1995). Substance P and stress-induced changes in macrophages. Ann. N.Y. Acad. Sci., 771, 472-484.
41. Chen, G., & Reichlin, S. (1999). Mechanisms by which blood levels of interleukin-6 (IL-6) are elevated after intracerebroventricular injection of IL-1β in the rat: Neural versus humoral control. Endocrinology, 140, 5549-5555.
42. Chen, J., Gao, J. P., Xu, C. T., Zhu, G. Q., & Liu, Y. (1991). The role of substance P in regulation of blood pressure and hypertension. Ann. N.Y. Acad. Sci., 632, 413-414.
43. Chowdrey, H. S., Larsen, P. J., Harbuz, M. S., Lightman, S. L., & Jessop, D. S. (1995). Endogenous substance P inhibits the expression of corticotropin-releasing hormone during a chronic inflammatory stress. Life Sci., 57, 2021-2029.
44. Chrousos, G. P. (1998). Stressors, stress, and neuroen-docrine integration of the adaptive response. The 1997 Hans Selye Memorial Lecture. Ann. N.Y. Acad. Sci., 851, 311-335.
45. Chrousos, G. P., & Gold, P. W. (1992). The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA, 267, 1244-1252.
46. Church, M. K., Lowman, M. A., Rees, P. H., & Benyon, R. C. (1989). Mast cells, neuropeptides and inflammation. Agents Actions, 27, 8-16.
47. Coderre, T. J., Basbaum, A. I., Dallman, M. F., Helms, C., & Levine, J. D. (1990). Epinephrine exacerbates arthritis by an action at presynaptic B2-adrenoceptors. Neuroscience, 34, 521-523.
48. Coderre, T. J., Basbaum, A. I., & Levine, J. D. (1989). Neural control of vascular permeability: Interactions between primary afferents, mast cells, and sympathetic efferents. J. Neurophysiol., 62, 48-58.
49. Coe, C. L., Rosenberg, L. T., & Levine, S. (1988). Prolonged effect of pyschological disturbance on macrophage chemiluminescence in the squirrel monkey. Brain Behav. Immun., 2, 151-160.
50. Corti, M. C., Gaziano, M., & Hennekens, C. H. (1997). Iron status and risk of cardiovascular disease. Ann. Epidemiol., 7, 62-68.
51. Crofford, L. J., Sano, H., Karalis, K., Webster, E. A., Friedman, T. C., Chrousos, G. P., & Wilder, R. L. (1995). Local expression of corticotropin-releasing hormone in inflammatory arthritis. Ann. N.Y. Acad. Sci., 771, 459-471.
52. Culman, J., & Unger, T. (1995). Central tachykinins: Mediators of defence reaction and stress reactions. Can. J. Physiol. Pharmacol., 73, 885-891.
53. Daemen, M. A., Kurvers, H. A., Kitslaar, P. J., Slaaf, D. W., Bullens, P. H., & van den Wildenberg, F. A. (1998). Neurogenic inflammation in an animal model of neuropathic pain. Neurol. Res., 20, 41-45.
54. Dallman, M. F., & Jones, M. T. (1973). Corticosteroid feedback control of ACTH secretion: Effect of stress-induced corticosterone secretion on subsequent stress responses in the rat. Endocrinology, 92, 1367-1375.
55. Dantzer, R., Bluthe, R. M., Laye, S., Bret-Dibat, J. L., Parnet, P., & Kelley, K. W. (1998). Cytokines and sickness behavior. Ann. N.Y. Acad. Sci., 840, 586-590.
56. Dantzer, R., Wollman, E. E., Vitkovic, L., & Yirmiya, R. (1999). Cytokines, stress, and depression. Conclusions and perspectives. Adv. Exp. Med. Biol., 461, 317-329.
57. De Simoni, M. G., Del Bo, R., De Luigi, A., Simard, S., & Forloni, G. (1995). Central endotoxin induces different patterns of interleukin (IL)-1β and IL-6 messenger ribonucleic acid expression and IL-6 secretion in the brain and periphery. Endocrinology, 136, 897-902.
58. Derijk, R. H., Boelen, A., Tilders, F. J., & Berkenbosch, F. (1994). Induction of plasma interleukin-6 by circulating adrenaline in the rat. Psychoneuroendocrinology, 19, 155-163.
59. Dhabhar, F. S., Miller, A. H., McEwen, B. S., & Spencer, R. L. (1995a). Differential activation of adrenal steroid receptors in neural and immune tissues of Sprague Dawley. J. Neuroimmunol., 56, 77-90.
60. Dhabhar, F. S., Miller, A. H., McEwen, B. S., & Spencer, R. L. (1995b). Effects of stress on immune cell distribution; Dynamics and hormonal mechanisms. J. Immunol., 154, 5511-5527.
61. Dhabhar, F. S., Miller, A. H., McEwen, B. S., & Spencer, R. L. (1996). Stress-induced changes in blood leukocyte distribution; Role of adrenal steroid hormones. J. Immunol., 157, 1638-1644.
62. Donnerer, J., Amann, R., Skofitsch, G., & Lembeck, F. (1991). Substance P afferents regulate ACTH-corticosterone release. Ann. N.Y. Acad. Sci., 632, 296-303.
63. Donnerer, J., Eglezos, A., & Helme, R. D. (1990). Neuroendocrine and immune function in the capsaicin-treated rat: Evidence for different neural modulation in vivo. In S. Freier (Ed.), The Neuroendocrine-Immune Network (pp. 69-83). Boca Raton: CRC Press.
64. Dulaney, R., Macaluso, A., Woerner, J., Hiltz, A., Catania, A., & Lipton, J. M. (1992). Changes in peripheral inflammation induced by CNS actions of an a-MSH analog and of endogenous pyrogen. Prog. Neuroendocrinimmunol., 5, 179-186.
65. Dwight, M. M., & Stoudemire, A. (1997). Effects of depressive disorders on coronary artery disease: A review. Harv. Rev. Psychiatry, 5, 115-122.
66. Elenkov, L. J., Papanicolaou, D. A., Wilder, R. L., & Chrousos, G. P. (1996). Modulatory effects of glucocorticoid and catecholamines on human interleukin-12 and interleukin-10 production: Clinical implications. Proc. Assoc. Am. Phys., 108, 374-381.
67. Emancipator, K., Csako, G., & Elin, R. J. (1992). In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins. Infect. Immun., 60, 596-601.
68. Fehder, W. P., Sachs, J., Uvaydova, M., & Douglas, S. D. (1997). Substance P as an immune modulator of anxiety. Neuroimmunomodulation, 4, 42-48.
69. Fisher, L. A. (1993). Central actions of corticotropin-releasing factor on autonomic nervous activity and cardiovascular functioning. Ciba Found. Symp., 172, 243-253.
70. Foreman, J. C. (1987). Peptides and neurogenic inflammation. Br. Med. Bull., 43, 386-400.
71. Francis, D. D., Champagne, F. A., Liu, D., & Meaney, M. J. (1999). Maternal care, gene expression, and the development of individual differences in stress reactivity. In N. E. Adler, M. Marmot, B. S. McEwen, & J. Stewart (Eds.), Socioeconomic Status and Health in Industrial Nations: Social, Psychological, and Biological Pathways (pp. 66-84). New York: New York Academy of Sciences.
72. Freidin, M., Bennett, M. V., & Kessler, J. A. (1992). Cultured sympathetic neurons synthesize and release the cytokine interleukin 1β. Proc. Natl. Acad. Sci. USA, 89, 10440-10443.
73. Freidin, M., & Kessler, J. A. (1991). Cytokine regulation of substance P expression in sympathetic neurons. Proc. Natl. Acad. Sci. USA, 88, 3200-3203.
74. Furie, M. B., & Randolph, G. J. (1995). Chemokines and tissue injury. Am. J. Pathol., 146, 1287-1301.
75. Gabay, C., & Kushner, I. (2000). Acute phase proteins and other systemic responses to inflammation. N. Engl. J. Med., 340, 448-454.
76. Gaffin, S. L., Brock-Utne, J. G., Zanotti, A., & Wells, M. T. (1986). Hypoxia-induced endotoxemia in primates: Role of reticuloendothelial system function and anti-lipopolysaccharide plasma. Aviation, Space Environ. Med., 57, 1044-1049.
77. Gaffin, S. L., & Hubbard, R. (1996). Experimental approaches to therapy and prophylaxis for heat stress and heatstroke. Wilderness Environ. Med., 4, 312-334.
78. Gathiram, P., Gaffin, S. L., Brock-Utne, J. G., & Wells, M. T. (1987). Time course of endotoxemia and cardiovascular changes in heat-stressed primates. Aviation, Space Environ. Med., 58, 1071-1074.
79. Gathiram, P., Wells, M. T., Raidoo, D., Brock-Utne, J. G., & Gaffin, S. L. (1989). Changes in lipopolysaccharide concentrations in hepatic portal and systemic plasma during intestinal ischemia in monkeys. Circ. Shock, 27, 103-109.
80. Gelin, J. L., Moldawer, L. L., Iresjo, B. M., & Lundholm, K. G. (1993). The role of the adrenals in the acute phase response to interleukin-1 and tumor necrosis factor α. J. Surg. Res., 54, 70-78.
81. Geppetti, P., Bertrand, C., Ricciardolo, F. L., Nadel, J. A., & Ricciardolo, F. M. (1995). New aspects on the role of kinins in neurogenic inflammation. Can. J. Physiol. Pharmacol., 73, 843-847.
82. Glassman, A. H., & Shapiro, P. A. (1998). Depression and the course of coronary artery disease. Am. J. Psychiatry, 155, 4-11.
83. Glick, E. N. (1967). Asymmetrical rheumatoid arthritis after poliomyelitis. Br. Med. J., 3, 26-28.
84. Gold, M. S., White, D. M., Ahlgren, S. C., Guo, M., & Levine, J. D. (1994). Catecholamine-induced mechanical sensitization of cutaneous nociceptors in the rat. Neurosci. Lett., 175, 166-170.
85. Gonzales, R., Coderre, T. J., Sherbourne, C. D., & Levine, J. D. (1991). Postnatal development of neurogenic inflammation in the rat. Neurosci. Lett., 127, 25-27.
86. Green, P. G., Janig, W., & Levine, J. D. (1997). Negative feedback neuroendocrine control of inflammatory response in the rat is dependent on the sympathetic postganglionic neuron. J. Neurosci., 17, 3234-3238.
87. Green, P. G., Luo, J., Heller, P., & Levine, J. D. (1993a). Modulation of bradykinin-induced plasma extravasation in the rat knee joint by sympathetic co-transmitters. Neuroscience, 52, 451-458.
88. Green, P. G., Luo, J., Heller, P. H., & Levine, J. D. (1993b). Further substantiation of a significant role for the sympathetic nervous system in inflammation. Neuroscience, 55, 1037-1043.
89. Green, P. G., Luo, J., Heller, P. H., & Levine, J. D. (1993c). Neurogenic and non-neurogenic mechanisms of plasma extravasation in the rat. Neuroscience, 52, 735-743.
90. Green, P. G., Miao, F. J., Janig, W., & Levine, J. D. (1995). Negative feedback neuroendocrine control of the inflammatory response in rats. J. Neurosci., 15, 4678-4686.
91. Green, P. G., Miao, F. J., Strausbaugh, H., Heller, P., Janig, W., & Levine, J. D. (1998). Endocrine and vagal controls of sympathetically dependent neurogenic inflammation. Ann. N.Y. Acad. Sci., 840, 282-288.
92. Gutwald, J., Goebeler, M., & Sorg, C. (1991). Neuropeptides enhance irritant and allergic contact dermatitis. J. Invest. Dermatol., 96, 695-698.
93. Hadid, R., Spinedi, E., Giovambattista, A., Chautard, T., & Gaillard, R. C. (1996). Decreased hypothalamo-pituitary-adrenal axis response to neuroendocrine challenge under repeated endotoxemia. Neuroimmunomodulation, 3, 62-68.
94. Hanani, M., & Wood, J. D. (1992). Corticotropin-releasing hormone excites myenteric neurons in the guinea-pig small intestine. Eur. J. Pharmacol., 211, 23-27.
95. Hardardottir, L., Grunfeld, C., & Feingold, K. R. (1994). Effects of endotoxin and cytokines on lipid metabolism. Curr. Opin. Lipidol., 5, 207-215.
96. Harris, H. W., Grunfeld, C., Feingold, K. R., & Rapp, J. H. (1990). Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J. Clin. Invest., 86, 696-702.
97. Harris, H. W., Grunfeld, C., Feingold, K. R., Read, T. E., Kane, J. P., Jones, A. L., Eichbaum, E. B., Bland, G. F., & Rapp, J. H. (1993). Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J. Clin. Invest., 91, 1028-1034.
98. Hartung, H. P. (1988). Activation of macrophages by neuropeptides. Brain Behav. Immun., 2, 275-281.
99. Hjemdahl, P., Akerstedt, T., Pollare, T., & Gillberg, M.(1983). Influence of β-adrenoceptor blockade by metoprolol and propranolol on plasma concentrations and effects of noradrenaline and adrenaline during i.v. infusion. Acta Physiol. Scand. Suppl., 515, 45-53.
100. Horan, M. A., Brouwer, A., Barelds, R. J., Wientjens, R., Durham, S. K., & Knook, D. L. (1991). Changes in endotoxin sensitivity in ageing. Absorption, elimination and mortality. Mech. Ageing Dev., 57, 145-162.
101. Hori, T., Katafuchi, T., Take, S., Shimizu, N., & Niijima, A. (1995). The autonomic nervous system as a communication channel between the brain and immune system. Neuroimmunomodulation, 2, 203-215.
102. Hubsch, A. P., Powell, F. S., Lerch, P. G., & Doran, J. E. (1993). A reconstituted, apolipoprotein A-I containing lipoprotein reduces tumor necrosis factor release and attenuates shock in endotoxemic rabbits. Circ. Shock, 40, 14-23.
103. Irwin, M. (1993). Stress-induced immune suppression. Role of the autonomic nervous system. Ann. N.Y. Acad. Sci., 697, 203-218.
104. Jansco, N., Jansco-Gabor, A., & Szolcsanyi, J. (1967). Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capaicin. Br. J. Pharmacol. Chemother., 31, 138-151.
105. Jern, C., Eriksson, E., Tengborn, L., Risberg, B., Wadenvik, H., & Jern, S. (1989). Changes of plasma coagulation and fibrinolysis in response to mental stress. Thromb. Haemost., 62, 767-771.
106. Jessop, D. S., Chowdrey, H. S., Larsen, P. J., & Lightman, S. L. (1992). Substance P: Multifunctional peptide in the hypothalamo-pituitary system? J. Endocrinol., 132, 331-337.
107. Jiang, G., Morrow-Tesch, J. L., Beller, D. I., Levy, E. M., & Black, P. H. (1990). Immunosuppression in mice induced by cold water stress. Brain Behav. Immun., 4, 278-291.
108. Kannan, H., Tanaka, Y., Kunitake, T., Ueta, Y., Hayashida, Y., & Yamashita, H. (1996). Activation of sympathetic outflow by recombinant human interleukin-1β in conscious rats. Am. J. Physiol., 270, R479-R485.
109. Kapcala, L. P., Chautard, T., & Eskay, R. L. (1995). The protective role of the hypothalamic-pituitary-adrenal axis against lethality produced by immune, infectious, and inflammatory stress. Ann. N.Y. Acad. Sci., 771, 419-437.
110. Kaplan, J. R., & Manuck, S. B. (1994). Antiatherogenic effects of beta-adrenergic blocking agents: Theoretical, experimental and epidemiologic considerations. Am. Heart. J., 128, 1316-1328.
111. Kavelaars, A., van de Pol, M., Zijlstra, J., & Heijnen, C. J. (1997). β2-Adrenergic activation enhances interleukin-8 production by human monocytes. J. Neuroimmunol., 77, 211-216.
112. Keates, A. C., Castagliuolo, L., Qiu, B., Nikulasson, S., Sengupta, A., & Pothoulakis, C. (1998). CGRP upregulation in dorsal root ganglia and ileal mucosa during Clostridium difficile toxin A-induced enteritis. Am. J. Physiol., 274, G196-G202.
113. Kessler, J. A. (1985). Differential regulation of peptide and catecholamine characters in cultured sympathetic neurons. Neuroscience, 15, 827-839.
114. Kessler, J. A., Freidin, M. M., Kalberg, C., & Chandross, K. J. (1993). Cytokines regulate substance P expression in sympathetic neurons. Regul. Pept., 46, 70-75.
115. Kidd, B. L., Cruwys, S., Mapp, P. I., & Blake, D. R. (1992). Role of the sympathetic nervous system in chronic joint pain and inflammation. Ann. Rheum. Dis., 51, 1188-1191.
116. Kidd, B. L., Mapp, P. I., Gibson, S. J., Polak, J. M., O'Higgins, F., Buckland-Wright, J. C., & Blake, D. R. (1989). A neurogenic mechanism for symmetrical arthritis. Lancet, 2, 1128-1130.
117. Kimball, E. S., Persico, F. J., & Vaught, J. L. (1988). Substance P, neurokinin A, and neurokinin B induce generation of IL-1-like activity in P388D1 cells. Possible relevance to arthritic disease. J. Immunol., 141, 3564-3569.
118. Kinnman, E., & Levine, J. D. (1995). Sensory and sympathetic contributions to nerve injury-induced sensory abnormalities in the rat. Neuroscience, 64, 751-767.
119. Kiss, A., & Aguilera, G. (1992). Participation of α1-adrenergic receptors in the secretion of hypothalamic corticotropin-releasing hormone during stress. Neuroendocrinology, 56, 153-160.
120. Kitamura, H., Konno, A., Morimatsu, M., Jung, B. D., Kimura, K., & Saito, M. (1997). Immobilization stress increases hepatic IL-6 expression in mice. Biochem. Biophys. Res. Commun., 238, 707-711.
121. Kop, W. J. (1999). Chronic and acute psychological risk factors for clinical manifestations of coronary artery disease. Psychosom. Med., 61, 476-487.
122. Kopp, E. B., & Medzhitov, R. (1999). The Toll-receptor family and control of innate immunity. Curr. Opin. Immunol., 11, 13-18.
123. Kossmann, T., Hans, V. H., Imhof, H. G., Stocker, R., Grob, P., Trentz, O., & Morganti-Kossmann, C. (1995). Intrathecal and serum interleukin-6 and the acute-phase response in patients with severe traumatic brain injuries. Shock, 4, 311-317.
124. Kostoglou-Athanassiou, I., Jacobs, R. A., Satta, M. A., Dahia, P. L., Costa, A., Navarra, P., Chew, S. L., Forsling, M. L., & Grossman, A. B. (1998). Acute and subacute effects of endotoxin on hypothalamic gaseous neuromodulators. Ann. N.Y. Acad. Sci., 840, 249-261.
125. Kostrzewa, R. M., & Jacobowitz, D. M. (1974). Pharmacological actions of 6-hydroxydopamine. Pharmacol. Rev., 26, 199-288.
126. Kozin, F., McCarty, D. J., Sims, J., & Genant, H. (1976). The reflex sympathetic dystrophy syndrome. I. Clinical and histologic studies: Evidence for bilaterality, response to corticosteroids and articular involvement. Am. J. Med., 60, 321-331.
127. Kramer, M. S., Cutler, N., Feighner, J., Shrivastava, R., Carman, J., Sramek, J. J., Reines, S. A., Liu, G., Snavely, D., Wyatt-Knowles, E., Hale, J. J., Mills, S. G., MacCoss, M., Swain, C. J., Harrison, T., Hill, R. G., Hefti, F., Scolnick, E. M., Cascieri, M. A., Chicchi, G. G., Sadowski, S., Williams, A. R., Hewson, L., Smith, D., & Rupniak, N. M. (1998). Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science, 281, 1640-1645.
128. Kurosawa, M., Sato, A., Swenson, R. S., & Takahashi, Y. (1986). Sympatho-adrenal medullary functions in response to intracerebroventricularly injected corticotropin-releasing factor in anesthetized rats. Brain Res., 367, 250-257.
129. Kvetnansky, R., Weise, V. K., Thoa, N. B., & Kopin, I. J. (1979). Effects of chronic guanethidine treatment and adrenal medullectomy on plasma levels of catecholamines and corticosterone in forcibly immobilized rats. J. Pharmacol. Exp. Ther., 209, 287-291.
130. Leeman, S. E., & Mroz, E. A. (1974). Substance P. Life Sci., 15, 2033-2044.
131. LeMay, L. G., Vander, A. J., & Kluger, M. J. (1990). The effects of psychological stress on plasma interleukin-6 activity in rats. Physiol. Behav., 47, 957-961.
132. Len, W. B., Tsou, M. Y., Chan, S. H., & Chan, J. Y. (1994). Substance P suppresses the activity of α2-adrenoceptors of the nucleus reticularis gigantocellularis involved in cardiovascular regulation in the rat. Brain Res., 638, 227-234.
133. Lenz, H. J. (1993). Regulation of small intestinal and pancreaticobiliary functions by CRF. Ann. N.Y. Acad. Sci., 697, 254-259.
134. Leon, M., Chan, P., Volteas, N., Labropoulos, N., & Nicolaides, A. (1993). Progression of carotid arteriosclerosis. Three year follow-up and analysis of risk factors. J. Cardiovas. Surg., 34, 461-464.
135. Levenson, J., Giral, P., Megnien, J. L., Gariepy, J., Plainfosse, M. C., & Simon, A. (1997). Fibrinogen and its relations to subclinical extracoronary and coronary atherosclerosis in hypercholesterolemic men. Arterioscler. Thromb. Vasc. Biol., 17, 45-50.
136. Levenson, J., Giral, P., Razavian, M., Gariepy, J., & Simon, A. (1995). Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors. Arterioscler. Thromb. Vasc. Biol., 15, 1263-1268.
137. Levine, J. D., Clark, R., Devor, M., Helms, C., Moskowitz, M. A., & Basbaum, A. I. (1984). Intraneuronal substance P contributes to the severity of experimental arthritis. Science, 226, 547-549.
138. Levine, J. D., Dardick, S. J., Basbaum, A. I., & Scipio, E. (1985). Reflex neurogenic inflammation. I. Contribution of the peripheral nervous system to spatially remote inflammatory responses that follow injury. J. Neurosci., 5, 1380-1386.
139. Levine, J. D., Fye, K., Heller, P., Basbaum, A. I., & Whiting-O'Keefe, Q. (1986). Clinical response to regional intravenous guanethidine in patients with rheumatoid arthritis. J. Rheumatol., 13, 1040-1043.
140. Levine, J. D., Goetzl, E. J., & Basbaum, A. I. (1987). Contribution of the nervous system to the pathophysiology of rheumatoid arthritis and other polyarthritides. Rheum. Dis. Clin. North Am., 13, 369-383.
141. Liao, J., Keiser, J. A., Scales, W. E., Kunkel, S. L., & Kluger, M. J. (1995). Role of epinephrine in TNF and IL-6 production from isolated perfused rat liver. Am. J. Physiol., 268, R896-R901.
142. Licinio, J., & Wong, M. L. (1999). The role of inflammatory mediators in the biology of major depression: Central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol. Psychiatry, 4, 317-327.
143. Lipton, J. M., & Catania, A. (1998). Mechanisms of anti-inflammatory action of the neuroimmunomodulatory peptide α-MSH. Ann. N.Y. Acad. Sci., 840, 373-380.
144. Lipton, J. M., Ceriani, G., Macaluso, A., McCoy, D., Carnes, K., Biltz, J., & Catania, A. (1994). Antiinflammatory effects of the neuropeptide α-MSH in acute, chronic, and systemic inflammation. Ann. N.Y. Acad. Sci., 741, 137-148.
145. Lipton, J. M., Zhao, H., Ichiyama, T., Barsh, G. S., & Catania, A. (1999). Mechanisms of antiinflammatory action of α-MSH peptides. In vivo and in vitro evidence. Ann. N.Y. Acad. Sci., 885, 173-182.
146. Livett, B., Zhou, X., Khalil, Z., Wan, D., Bunn, S., & Marley, P. (1989). Endogenous neuropeptides maintain adrenal catecholamine output during stress. In S. Breznitz & O. Zinder (Eds.), Molecular Biology of Stress (pp. 179-190). New York: Alan R. Liss Inc.
147. Lloyds, D., Brindle, N. P., & Hallett, M. B. (1995). Priming of human neutrophils by tumour necrosis factor-α and substance P is associated with tyrosine phosphorylation. Immunology, 84, 220-226.
148. Lorton, D., Bellinger, D. L., Felten, S. Y., & Felten, D. L. (1991). Substance P innervation of spleen in rats: Nerve fibers associate with lymphocytes and macrophages in specific compartments of the spleen. Brain Behav. Immun., 5, 29-40.
149. Lowe, G. D., Yarnell, J., W, Sweetnam, P. M., Rumley, A., Thomas, H. F., & Elwood, P. C. (1998). Fibrin D-dimer, tissue plasminogen activator, plasminogen activator inhibitor, and the risk of major ischaemic heart disease in the Caerphilly study. Thromb. Haemost., 79, 129-133.
150. Lowy, M. T., Wittenberg, L., & Yamamoto, B. K. (1995). Effect of acute stress on hippocampal glutamate levels and spectrin proteolysis in young and aged rats. J. Neurochem., 65, 268-274.
151. MacQueen, G., Marshall, J., Perdue, M., Siegel, S., & Bienenstock, J. (1989). Pavlovian conditioning of rat mucosal mast cells to secrete rat mast cell protease II. Science, 243, 83-85.
152. Maes, M., Bosmans, E., Suy, E., Minner, B., & Raus, J. (1989). Impaired lymphocyte stimulation by mitogens in severely depressed patients. Br. J. Psychiatry, 155, 793-798.
153. Maes, M., Hendriks, D., Van Gastel, A., Demedts, P., Wauters, A., Neels, H., Janca, A., & Scharpe, S. (1997a). Effects of psychological stress on serum immunoglobulin, complement and acute phase protein concentrations in normal volunteers. Psychoneuroendocrinology, 22, 397-409.
154. Maes, M., Scharpe, S., Meltzer, H. Y., Bosmans, E., Suy, E., Calabrese, J., & Cosyns, P. (1993). Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Res., 49, 11-27.
155. Maes, M., Smith, R., Christophe, A., Vandoolaeghe, E., Van Gastel, A., Neels, H., Demedts, P., Wauters, A., & Meltzer, H. Y. (1997b). Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: Relationship with immune-inflammatory markers. Acta Psychiatry Scand., 95, 212-221.
156. Maier, S. F., Nguyen, K. T., Deak, T., Milligan, E. D., & Watkins, L. R. (1999). Stress, learned helplessness, and brain interleukin-1β. Adv. Exp. Med. Biol., 461, 235-249.
157. Maier, S. F., & Watkins, L. R. (1998). Cytokines for psychologists: Implications for bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol. Rev., 105, 83-107.
158. Majno, G., & Palade, G. (1961). Studies on inflammation. I. The effects of histamine and serotonin in vascular permability: An electron microscopic study. J. Biophys. Biochem. Cytol., 11, 571-605.
159. Manuck, S. B., Marsland, A. L., Kaplan, J. R., & Williams, J. K. (1995). The pathogenicity of behavior and its neuroendocrine mediation: An example from coronoary artery disease. Psychosom. Med., 57, 275-283.
160. Marriott, I., & Bost, K. L. (1998). Substance P diminishes lipopolysaccharide and interferon-γ-induced TGF-β1 production by cultured murine macrophages. Cell. Immunol., 183, 113-120.
161. Marshall, J. S., & Waserman, S. (1995). Mast cells and the nerves-potential interactions in the context of chronic disease. Clin. Exp. Allergy, 25, 102-110.
162. Matthews, K. A., Owens, J. F., Kuller, L. H., Sutton-Tyrell, K., Lassila, H. C., & Wolfson, S. K. (1998). Stress-induced pulse pressure change predicts women's carotid atherosclerosis. Stroke, 29, 1525-1530.
163. McCann, B. S., Magee, M. S., Broyles, F. C., Vaughan, M., Albers, J. J., & Knopp, R. H. (1995). Acute psychological stress and epinephrine infusion in normolipidemic and hyperlipidemic men: Effects on plasma lipid and apoprotein concentrations. Psychosom. Med., 57, 165-176.
164. McCarty, R., & Gold, P. E. (1996). Catecholamines, stress, and disease: A psychobiological perspective. Psychosom. Med., 58, 590-597.
165. McCully, K. S. (1996). Homocysteine and vascular disease. Nat. Med., 2, 386-389.
166. McEwen, B. S. (1998). Protective and damaging effects of stress medicine. Semin. Med. Beth Israel Deaconess Medical Center, 338, 171-179.
167. McEwen, B. S., Biron, C. A., Brunson, K. W., Bulloch, K., Chambers, W. H., Dhabhar, F. S., Goldfarb, R. H., Kitson, R. P., Miller, A. H., Spencer, R. L., & Weiss, J. M. (1997). The role of adrenocorticoids as modulators of immune function in health and disease: Neural, endocrine and immune interactions. Brain Res. Rev., 23, 79-133.
168. McEwen, B. S., & Gould, E. (1990). Adrenal steroid influences on the survival of hippocampal neurons. Biochem. Pharmacol., 40, 2393-2402.
169. McEwen, B. S., & Seeman, T. (1999). Protective and damaging effects of mediators of stress. Elaborating and testing the concepts of allostasis and allostatic load. Ann. N.Y. Acad. Sci., 896, 30-47.
170. McGillis, J. P., Organist, M. L., & Payan, D. G. (1987). Substance P and immunoregulation. Fed. Proc., 46, 196-199.
171. McKay, D. M., & Bienenstock, J. (1994). The interaction between mast cells and nerves in the gastrointestinal tract. Immunol. Today, 15, 533-538.
172. Meggs, W. J. (1993). Neurogenic inflammation and sensitivity to environmental chemicals. Environ. Health Perspect., 101, 234-238.
173. Meggs, W. J. (1995). Neurogenic switching: A hypothesis for a mechanism for shifting the site of inflammation in allergy and chemical sensitivity. Environ. Health Perspect., 103, 54-56.
174. Merchenthaler, I, Hynes, M. A., Vigh, S., Shally, A. V., & Petrusz, P. (1983). Immunocytochemical localization of corticotropin releasing factor (CRF) in the rat spinal cord. Brain Res., 275, 373-377.
175. Miao, F. J., Benowitz, N. L., Heller, P. H., & Levine, J. D. (1997). Contribution of adrenal hormones to nicotine-induced inhibition of synovial plasma extravasation in the rat. Br. J. Pharmacol., 120, 298-304.
176. Mimura, Y., Sakisaka, S., Harada, M., Sata, M., & Tanikawa, K. (1995). Role of hepatocytes in direct clearance of lipopolysaccharide in rats. Gastroenterology, 109, 1969-1976.
177. Miura, H., Gardemann, A., Rosa, J., & Jungermann, K. (1992). Inhibition by noradrenaline and adrenaline of the increase in glucose and lactate output and decrease in flow after sympathetic nerve stimulation in perfused rat liver: Possible involvement of protein kinase C. Hepatology, 15, 477-484.
178. Moore, T. (1993). Substance P. In T. Moore (Ed.), Neurovascular Immunology: Vasoactive Neurotransmitters and Modulators in Cell Immunity (pp. 247-311). Boca Raton: CRC Press.
179. Morimoto, A., Watanabe, T., Myogin, T., & Murakami, N. (1987). Restraint induced stress elicits acute phase response in rabbits. Eur. J. Physiol., 410, 554-556.
180. Morrow, L. E., McClellan, J. L., Conn, C. A., & Kluger, M. J. (1993). Glucocorticoids alter fever and IL-6 responses to psychological stress and to lipopolysaccharide. Am. J. Physiol., 264(5Pt2), R1010-R1016.
181. Munck, A., Guyre, P. M., & Holbrook, N. J. (1984). Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr. Rev., 5, 25-44.
182. Munck, A., & Naray-Fejes-Toth, A. (1994). Glucocorticoids and stress: Permissive and suppressive actions. Ann. N.Y. Acad. Sci., 746, 115-130.
183. Musselman, D. L., Evans, D. L., & Nemeroff, C. B. (1998). The relationship of depression to cardiovascular disease: Epidemiology, biology, and treatment. Arch. Gen. Psychiatry, 55, 580-592.
184. Niaura, R., Stoney, C. M., & Herbert, P. N. (1992). Lipids in psychological research: The last decade. Biol. Psychol., 34, 1-43.
185. Niijima, A. (1982). Glucose-sensitive afferent nerve fibres in the hepatic branch of the vagus nerve in the guinea-pig. J. Physiol. (Lond.), 332, 315-323.
186. Niijima, A. (1996). The afferent discharges from sensors for interleukin 1β in the hepatoportal system in the anesthetized rat. J. Auton. Nerv. Syst., 61, 287-291.
187. Nio, D. A., Moylan, R. N., & Roche, J. K. (1993). Modulation of T lymphocyte function by neuropeptides. Evidence for their role as local immunoregulatory elements. J. Immunol., 150, 5281-5288.
188. Nordlind, K., Libing, C., Ahmed, A. A., Ljungberg, A., & Liden, S. (1995). Immunohistochemical localization of interleukin-6-like immunoreactivity to peripheral nerve-like structures in normal and inflamed human skin. Ann. N.Y. Acad. Sci., 762, 450-451.
189. Numao, T., & Agrawal, D. K. (1992). Neuropeptides modulate human eosinophil chemotaxis. J. Immunol., 149, 3309-3315.
190. Nussdorfer, G. G., Malendowicz, L. K., Meneghelli, V., & Mazzocchi, G. (1991). Neurotensin enhances plasma adrenocorticotropin concentration by stimulating corticotropin-releasing hormone secretion. Life Sci., 50, 639-643.
191. Okano, K., Kuraishi, Y., & Satoh, M. (1995). Effects of intrathecally injected glutamate and substance P antagonists on repeated cold stress-induced hyperalgesia in rats. Biol. Pharm. Bull., 18, 42-44.
192. Otsuka, M., & Yoshioka, K. (1993). Neurotransmitter functions of mammahan tachykinins. Physiol. Rev., 73, 229-308.
193. Ottaway, C. A., & Husband, A. J. (1994). The influence of neuroendocrine pathways on lymphocyte migration. Immunol. Today, 15, 511-517.
194. Palkovits, M., Baffi, J. S., & Dvori, S. (1995). Neuronal organization of stress response. Pain-induced c-fos expression in brain stem catecholaminergic cell groups. Ann. N.Y. Acad. Sci., 771, 313-326.
195. Papa, M., Halperin, Z., Rubinstein, E., Orenstein, A., Gafin, S., & Adar, R. (1983). The effect of ischemia of the dog's colon on transmural migration of bacteria and endotoxin. J. Surg. Res., 35, 264-269.
196. Patel, H., Fellowes, R., Coade, S., & Woo, P. (1998). Human serum amyloid A has cytokine-like properties. Scand. J. Immunol., 48, 410-418.
197. Payan, D. G. (1989). Neuropeptides and inflammation: The role of substance P. Annu. Rev. Med., 40, 341-352.
198. Peck, R. (1987). Neuropeptides modulating macrophage function. Ann. N.Y. Acad. Sci., 496, 264-270.
199. Pernow, B. (1983). Substance P. Pharmacol. Rev., 35, 85-141.
200. Peterson, P. D., Chan, C. C., & Molitor, M. (1991). Stress and pathogenesis of infectious disease. Rev. Infec. Dis., 13, 710-713.
201. Pickering, T. (1999). Cardiovascular pathways: Socioeconomic status and stress effects on hypertension and cardiovascular function. In N. E. Adler, M. Marmot, B. S. McEwen, & J. Stewart (Eds.), Socioeconomic Status and Health in Industrial Nations: Social, Psychological, and Biological Pathways (pp. 262-277). New York: New York Academy of Sciences.
202. Pierce, P. A., Xie, G. X., Peroutka, S. J., Green, P. G., & Levine, J. D. (1995). 5-Hydroxytryptamine-induced synovial plasma extravasation is mediated via 5-hydroxytryptamine2A receptors on sympathetic efferent terminals. J. Pharmacol. Exp. Ther., 275, 502-508.
203. Pincelli, C., Fantini, F., & Giannetti, A. (1993). Neuropeptides and skin inflammation. Dermatology, 187, 153-158.
204. Pothoulakis, C., Castagliuolo, I., & LaMont, J. T. (1998a). Nerves and intestinal mast cells modulate responses to enterotoxins. News. Physiol. Sci., 13, 58-63.
205. Pothoulakis, C., Castagliuolo, I., LaMont, J. T., Jaffer, A., O3Keane, J. C., Snider, R. M., & Leeman, S. E. (1994). CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin. Proc. Natl. Acad. Sci. USA, 91, 947-951.
206. Pothoulakis, C., Castagliuolo, I., & Leeman, S. E. (1998b). Neuroimmune mechanisms of intestinal responses to stress. Role of corticotropin-releasing factor and neurotensin. Ann. N.Y. Acad. Sci., 840, 635-648.
207. Pothoulakis, C., Castagliuolo, I., Leeman, S. E., Wang, C. C., Li, H., Hoffman, B. J., & Mezey, E. (1998c). Substance P receptor expression in intestinal epithelium in Clostridium difficile toxin A enteritis in rats. Am. J. Physiol., 275, G68-G75.
208. Proppe, D. W. (1980). α-Adrenergic control of intestinal circulation in heat-stressed baboons. J. Appl. Physiol.: Respirat. Environ. Exerc. Physiol., 48, 759-764.
209. Purcell, W. M., & Atterwill, C. K. (1995). Mast cells in neuroimmune function: Neurotoxicological and neuropharmacological perspectives. Neurochem. Res., 20, 521-532.
210. Raikkonen, K., Keltikangas-Jarvinen, L., Adlercreutz, H., & Hautanen, A. (1996a). Psychosocial stress and the insulin resistance syndrome. Metabolism, 45, 1533-1538.
211. Raikkonen, K., Lassila, R., Keltikangas-Jarvinen, L., & Hautanen, A. (1996b). Association of chronic stress with plasminogen activator inhibitor-1 in healthy middle-aged men. Arterioscler. Thromb. Vasc. Biol., 16, 363-367.
212. Rameshwar, P., Ganea, D., & Gascon, P. (1993). In vitro stimulatory effect of substance P on hematopoiesis. Blood, 81, 391-398.
213. Rameshwar, P., & Gascon, P. (1995). Substance P (SP) mediates production of stem cell factor and interleukin-1 in bone marrow stroma: Potential autoregulatory role for these cytokines in SP receptor expression and induction. Blood, 86, 482-490.
214. Rang, H. P., Bevan, S., & Dray, A. (1991). Chemical activation of nociceptive peripheral neurones. Br. Med. Bull., 47, 534-548.
215. Reaven, G. M., Lithell, H., & Landsberg, L. (1996). Hypertension and associated metabolic abnormalities - The role of insulin resistance and the sympathoadrenal system. N. Engl. J. Med., 334, 374-381.
216. Reichlin, S. (1998). Alternative pathways of neural control of the immune process. Ann. N.Y. Acad. Sci., 840, 301-316.
217. Reichlin, S. (1999). Neuroendocrinology of infection and the innate immune system. Recent Prog. Horm. Res., 54, 133-183.
218. Reul, J. M., Labeur, M. S., Wiegers, G. J., & Linthorst, A. C. (1998). Altered neuroimmunoendocrine communication during a condition of chronically increased brain corticotropin-releasing hormone drive. Ann. N.Y. Acad. Sci., 840, 444-455.
219. Reyes, T. M., & Coe, C. L. (1997). Prenatal manipulations reduce the proinflammatory response to a cytokine challenge in juvenile monkeys. Brain Res., 769, 29-35.
220. Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997). Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med., 336, 973-979.
221. Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1998). Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation, 97, 425-428.
222. Ridker, P. M., Gaboury, C. L., Conlin, P. R., Seely, E. W., Williams, G. H., & Vaughan, D. E. (1993a). Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function. Circulation, 87, 1969-1973.
223. Ridker, P. M., Vaughan, D. E., Stampfer, M. J., Manson, J. E., & Hennekens, C. H. (1993b). Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet, 341, 1165-1168.
224. Riegler, M., Castagliuolo, L., Wang, C., Wlk, M., Sogukoglu, T., Wenzl, E., Matthews, J. B., & Pothoulakis, C. (2000). Neurotensin stimulates Cl(-) secretion in human colonic mucosa in vitro: Role of adenosine. Gastroenterology, 119, 348-357.
225. Roberts, W. J. (1986). A hypothesis on the physiological basis for causalgia and related pains. Pain, 24, 297-311.
226. Rosen, A., Brodin, K., Eneroth, P., & Brodin, E. (1992). Short-term restraint stress and s.c. saline injection alter the tissue levels of substance P and cholecystokinin in the peri-aqueductal grey and limbic regions of rat brain. Acta Physiol. Scand., 146, 341-348.
227. Ross, R. (1999). Atherosclerosis - An inflammatory disease. N. Engl. J. Med., 340, 115-126.
228. Rozanski, A., Blumenthal, J. A., & Kaplan, J. (1999). Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation, 99, 2192-2217.
229. Russell, M., Dark, K. A., Cummins, R. W., Ellman, G., Callaway, E., & Peeke, H. V. (1984). Learned histamine release. Science, 225, 733-734.
230. Ruzek, M. C., Miller, A. H., Opal, S. M., Pearce, B. D., & Biron, C. A. (1997). Characterization of early cytokine responses and an interleukin (IL)-6- dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection. J. Exp. Med., 185, 1185-1192.
231. Sapolsky, R. M. (1990). Glucocorticoids, hippocampal damage and glutaminergic synapse. In E. Coleman, G. Higgins, & C. Phelps (Eds.), Brain Res., Vol. 86 (pp. 13-23). Amsterdam: Elsevier.
232. Sapolsky, R. M., Krey, L. C., & McEwen, B. S. (1986). The neuroendocrinology of stress and aging: The glucocorticoid cascade hypothesis. Endocr. Rev., 1986, 284-301.
233. Sato, J., & Perl, E. R. (1991). Adrenergic excitation of cutaneous pain receptors induced by peripheral nerve injury. Science, 251, 1608-1610.
234. Satoh, M., Kuraishi, Y., & Kawamura, M. (1992). Effects of intrathecal antibodies to substance P, calcitonin gene-related peptide and galanin on repeated cold stress-induced hyperalgesia: Comparison with carrageenan-induced hyperalgesia. Pain, 49, 273-278.
235. Schedlowski, M., Fluge, T., Richter, S., Tewes, U., Schmidt, R. E., & Wagner, T. O. (1995). β-Endorphin, but not substance-P, is increased by acute stress in humans. Psychoneuroendocrinology, 20, 103-110.
236. Seeman, T. E., Singer, B. H., Rowe, J. W., Horwitz, R. I., & McEwen, B. S. (1997). Price of adaptation - Allostatic load and its health consequences. MacArthur studies of successful aging. Arch. Intern. Med., 157, 2259-2268.
237. Seltzer, Z., Dubner, R., & Shir, Y. (1990). A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain, 43, 205-218.
238. Sesso, H. D., Kawachi, I., Vokonas, P. S., & Sparrow, D. (1998). Depression and the risk of coronary heart disease in the normative aging study. Am. J. Cardiol., 82, 851-856.
239. Shadiack, A. M., Hart, R. P., Carlson, C. D., & Jonakait, G. M. (1993). Interleukin-1 induces substance P in sympathetic ganglia through the induction of leukemia inhibitory factor (LIF). J. Neurosci., 13, 2601-2609.
240. Sherbourne, C. D., Gonzales, R., Goldyne, M. E., & Levine, J. D. (1992). Norepinephrine-induced increase in sympathetic neuron-derived prostaglandins is independent of neuronal release mechanisms. Neurosci. Lett., 139, 188-190.
241. Shyu, B. C., Danielsen, N., Andersson, S. A., & Dahlin, L. B. (1990). Effects of sympathetic stimulation on C-fibre response after peripheral nerve compression: An experimental study in the rabbit common peroneal nerve. Acta Physiol. Scand., 140, 237-243.
242. Singh, L. K., Pang, X., Alexacos, N., Letourneau, R., & Theoharides, T. C. (1999). Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing factor, neurotensin and substance P: A link to neurogenic skin disorders. Brain Behav. Immun., 13, 225-239.
243. Snyers, L., De Wit, L., & Content, J. (1990). Glucocorticoid upregulation of high affinity interleukin-6 receptors on human endothelial cells. Proc. Natl. Acad. Sci. USA, 87, 2838-2842.
244. Soszynski, D., Kozak, W., Conn, C. A., Rudolph, K., & Kluger, M. J. (1996). β-Adrenoceptor antagonists suppress elevation in body temperature and increase in plasma IL-6 in rats exposed to open field. Neuroendocrinology, 63, 459-467.
245. Spengler, R. N., Chensue, S. W., Giacherio, D. A., Blenk, N., & Kunkel, S. L. (1994). Endogenous norepinephine regulates tumor necrosis factor-α production from macrophages in vitro. J. Immunol., 152, 3024-3031.
246. Stead, R. H. (1992). Nerve remodelling during intestinal inflammation. Ann. N.Y. Acad. Sci., 664, 443-455.
247. Stead, R. H., Tomioka, M., Quinonez, G., Simon, G. T., Felten, S. Y., & Bienenstock, J. (1987). Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves. Proc. Natl. Acad. Sci. USA, 84, 2975-2979.
248. Sternberg, E. M., Hill, J. M., Chrousos, G. P., Kamilaris, T., Listwak, S. J., Gold, P. W., & Wilder, R. L. (1989a). Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc. Natl. Acad. Sci. USA, 86, 2374-2378.
249. Sternberg, E. M., Young III, W. S., Bernardini, R., Calogero, A. E., Chrousos, G. P., Gold, P. W., & Wilder, R. L. (1989b). A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc. Natl. Acad. Sci. USA, 86, 4771-4775.
250. Stoney, C. M., Niaura, R., Bausserman, L., & Matacin, M. (1999). Lipid reactivity to stress: I. Comparison of chronic and acute stress responses in middle-aged airline pilots. Health Psychol., 18, 241-250.
251. Suzuki, R., Furuno, T., McKay, D. M., Wolvers, D., Teshima, R., Nakanishi, M., & Bienenstock, J. (1999). Direct neurite-mast cell communication in vitro occurs via the neuropeptide substance P. J. Immunol., 163, 2410-2415.
252. Takaki, A., Huang, Q. H., & Arimura, A. (1996). Is immobilization-induced plasma IL-6 elevation regulated by hepatic innervation? In T. Shimazu (Ed.), Liver innervation (pp. 221-226). London: John Libbey.
253. Takaki, A., Huang, Q. H., Somogyvari-Vigh, A., & Arimura, A. (1994). Immobilization stress may increase plasma interleukin-6 via central and peripheral catecholamines. Neuroimmunomodulation, 1, 335-342.
254. Tarkowski, E., Rosengren, L., Blomstrand, C., Wikkelso, C., Jensen, C., Ekholm, S., & Tarkowski, A. (1995). Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke, 26, 1393-1398.
255. Theoharides, T. C., Sant, G. R., el Mansoury, M., Letourneau, R., Ucci, A. A., Jr., & Meares, E. M., Jr. (1995a). Activation of bladder mast cells in interstitial cystitis: A light and electron microscopic study. J. Urol., 153, 629-636.
256. Theoharides, T. C., Singh, L. K., Boucher, W., Pang, X., Letourneau, R., Webster, E., & Chrousos, G. (1998). Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology, 139, 403-413.
257. Theoharides, T. C., Spanos, C., Pang, X., Alferes, L., Ligris, K., Letourneau, R., Rozniecki, J. J., Webster, E., & Chrousos, G. P. (1995b). Stress-induced intracranial mast cell degranulation: A corticotropin-releasing hormone-mediated effect. Endocrinology, 136, 5745-5750.
258. Theorell, T., & Karasek, R. A. (1996). Current issues relating to psychosocial job strain and cardiovascular disease research. J. Occup. Health Psychol., 1, 9-26.
259. Thompson, M., & Bywaters, E. G. L. (1962). Unilateral rheumatoid arthritis following hemiplegia. Ann. Rheum. Dis., 21, 370-377.
260. Tsagarakis, S., Holly, J. M., Rees, L. H., Besser, G. M., & Grossman, A. (1988). Acetylcholine and norepinephrine stimulate the release of corticotropin-releasing factor-41 from the rat hypothalamus in vitro. Endocrinology, 123, 1962-1969.
261. Unger, T., Carolus, S., Demmert, G., Ganten, D., Lang, R. E., Maser-Gluth, C., Steinberg, H., & Veelken, R. (1988). Substance P induces a cardiovascular defense reaction in the rat: Pharmacological characterization. Circ. Res., 63, 812-820.
262. Unger, T., Rascher, W., Schuster, C., Pavlovitch, R., Schomig, A., Dietz, R., & Ganten, D. (1981). Central blood pressure effects of substance P and angiotensin II: Role of the sympathetic nervous system and vasopressin. Eur. J. Pharmacol., 71, 33-42.
263. Unger, T., Rockhold, R. W., Yukimura, T., Rettig, R., & Ganten, D. (1980). Blood pressure and heart rate responses to centrally administered substance P are increased in spontaneously hypertensive rats. Clin. Sci., 59(Suppl 6), 299s-302s.
264. Uno, H., Tarara, R., Else, J. G., Suleman, M. A., & Sapolsky, R. M. (1989). Hippocampal damage associated with prolonged and fatal stress in primates. J. Neurosci., 9, 1705-1711.
265. Valentino, R. J., Foote, S. L., & Page, M. E. (1993). The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses. Ann. N.Y. Acad. Sci., 697, 173-188.
266. van Gool, J., van Vugt, J., Helle, M., & Aarden, L. A. (1990). The relation among stress, adrenalin, interleukin-6 and acute phase reactants in the rat. Clin. Immunol. Immunopathol., 57, 200-210.
267. van Oosten, M., van de Bilt, E., van Berkel, T. J., & Kuiper, T. (1998). New scavenger receptor-like receptors for the binding of lipopolysaccharide to liver endothelial and Kupffer cells. Infect. Immun., 66, 5107-5112.
268. Vrijkotte, T. G., van Doornen, L. J., & de Geus, E. J. (1999). Work stress and metabolic and hemostatic risk factors. Psychosom. Med., 61, 796-805.
269. Wachulec, M., Peloso, E., & Satinoff, E. (1997). Individual differences in response to LPS and psychological stress in aged rats. Am. J. Physiol., 272(4Pt2), R1252-R1257.
270. Wallengren, J. (1997). Vasoactive peptides in the skin. J. Investig. Dermatol. Symp. Proc., 2, 49-55.
271. Watkins, L. R., Nguyen, K. T., Lee, J. E., & Maier, S. F. (1999). Dynamic regulation of proinflammatory cytokines. Adv. Exp. Med. Biol., 461, 153-178.
272. Watkins, L. R., Wiertelak, E. P., Goehler, L. E., Smith, K. P., Martin, D., & Maier, S. F. (1994). Characterization of cytokine-induced hyperalgesia. Brain Res., 654, 15-26.
273. Weinstock, J. V. (1992). Neuropeptides and the regulation of granulomatous inflammation. Clin. Immunol. Immunopathol., 64, 17-22.
274. Welch, G. N., & Loscalzo, J. (1998). Homocysteine and atherothrombosis. N. Engl. J. Med., 338, 1042-1050.
275. Wheeler-Aceto, H., & Cowan, A. (1991). Neurogenic and tissue-mediated components of formalin-induced edema: Evidence for supraspinal regulation. Agents Actions, 34, 264-269.
276. Wiegers, G. J., Labeur, M. S., Stec, I. E., Klinkert, W. E., Holsboer, F., & Reul, J. M. (1995). Glucocortic-oids accelerate anti-T-cell receptor-induced T-cell growth. J. Immunol., 155, 1893-1902.
277. Williams, R. B. (1994). Neurobiology, cellular and molecular biology, and psychosomatic medicine. Psychosom. Med., 56, 308-315.
278. Yamasu, K., Shimada, Y., Sakaizumi, M., Soma, G., & Mizuno, D. (1992). Activation of the systemic production of tumor necrosis factor after exposure to acute stress. Eur. Cytokine Netw., 3, 391-398.
279. Young, E. A., & Akil, H. (1988). Paradoxical effect of corticosteroids on pituitary ACTH/beta-endorphin release in stressed animals. Psychoneuroendocrinology, 13, 317-323.
280. Yuan, X. M., & Brunk, U. T. (1998). Iron and LDL-oxidation in atherogenesis. APMIS, 106, 825-842.
281. Zhong, J., & Heumann, R. (1995). Lesion-induced interleukin-6 mRNA expression in rat sciatic nerve. Ann. N.Y. Acad. Sci., 762, 488-490.
282. Zhou, D., Kusnecov, A. W., Shurin, M. R., DePaoli, M., & Rabin, B. S. (1993). Exposure to physical and psychological stressors elevates plasma interleukin-6: Relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology, 133, 2523-2530.
283. Zhou, X. F., & Livett, B. G. (1991). Capsaicin-sensitive sensory neurons are involved in the plasma catecholamine response of rats to selective stressors. J. Physiol. (Lond.), 433, 393-407.
284. Zhu, G. F., Chancellor-Freeland, C., Berman, A. S., Kage, R., Leeman, S. E., Beller, D. I., & Black, P. H. (1996). Endogenous substance P mediates cold water stress-induced increase in interleukin-6 secretion from peritoneal macrophages. J. Neurosci., 16, 3745-3752.
285. Zhu, X., & Desiderio, D. M. (1994). Effects of space flight stress on proopiomelanocortin, proenkephalin A, and tachykinin neuropeptidergic systems in the rat posterior pituitary. Life Sci., 55, 347-350.
286. Zukowska-Grojec, Z. (1995). Neuropeptide Y. A novel sympathetic stress hormone and more. Ann. N.Y. Acad. Sci., 771, 219-233.